Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also lower medical costs. The growth of the markets for telemedicine and drug eluting stents also demonstrate the growing trend in medicine of using cutting-edge technology to enhance clinical outcomes. MarketsandMarkets tracks vital medical devices markets such as orthopedic devices, cardiovascular devices, surgical devices, therapeutic devices, mobility assist devices, self diagnostic devices, and neurostimulators.
Medical devices refer to a broad range of instruments, machines, implants, apparatuses, software, or other similar items that are specifically designed and manufactured for medical purposes. These devices are used in the prevention, diagnosis, treatment, or management of diseases, injuries, or disabilities in humans.
Medical devices can vary in complexity and function. They can be as simple as tongue depressors, thermometers, or bandages, or as advanced as robotic surgical systems, pacemakers, or imaging machines such as MRI (Magnetic Resonance Imaging) scanners.
The primary objective of medical devices is to improve the quality of patient care by providing accurate and reliable diagnostic information, delivering therapies, or assisting in medical procedures. They are often regulated by governmental bodies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety, effectiveness, and quality.
Medical devices play a crucial role in modern healthcare and are utilized in various settings, including hospitals, clinics, ambulatory care centers, and home healthcare. They are developed through rigorous research, design, testing, and manufacturing processes to meet specific medical requirements and comply with relevant regulations and standards.
Futuristic scope –
The field of medical devices is constantly evolving, and there are several futuristic trends and advancements that hold great potential for improving healthcare in the coming years. Here are some areas with exciting prospects:
- Wearable Medical Devices: Wearable devices, such as smartwatches, fitness trackers, and biosensors, are already gaining popularity. In the future, these devices are expected to become more advanced, capable of monitoring a wide range of health parameters, including blood glucose levels, heart rhythm abnormalities, hydration levels, and more. They can provide real-time data and personalized feedback, enabling individuals to actively manage their health and allowing healthcare providers to deliver more precise care.
- Telemedicine and Remote Monitoring: Telemedicine and remote patient monitoring have witnessed significant growth, especially during the COVID-19 pandemic. The integration of medical devices with telemedicine platforms will allow patients to receive remote consultations and continuous monitoring of their health conditions. For instance, wearable devices combined with artificial intelligence (AI) algorithms can detect early signs of health deterioration and alert healthcare professionals, enabling proactive interventions and reducing hospitalizations.
- Robotics and Minimally Invasive Surgery: Robotic-assisted surgical systems have already revolutionized certain surgical procedures, offering increased precision and control to surgeons. As technology advances, we can expect more sophisticated robotic systems capable of performing complex surgeries with minimal invasiveness. These advancements may lead to shorter recovery times, reduced complications, and improved patient outcomes.
- Implantable Devices and Artificial Organs: Implantable medical devices, such as pacemakers and cochlear implants, have been transforming the lives of individuals with chronic conditions. In the future, we may see the development of more advanced implantable devices, including artificial organs and neural interfaces, that can restore or enhance the functioning of specific body systems. These devices could greatly improve the quality of life for people with disabilities or organ failures.
- Nanotechnology and Drug Delivery Systems: Nanotechnology has the potential to revolutionize drug delivery and improve targeted therapies. Nanoscale devices or nanoparticles can be engineered to deliver medications precisely to specific cells or tissues, enhancing their effectiveness while minimizing side effects. Additionally, nanosensors could be used for real-time monitoring of various biomarkers within the body, aiding in early disease detection and personalized treatment approaches.
- Artificial Intelligence and Machine Learning: AI and machine learning algorithms have the potential to analyze vast amounts of medical data and assist healthcare professionals in diagnosis, treatment planning, and decision-making. These technologies can help identify patterns, predict outcomes, and provide personalized recommendations based on individual patient data. AI-powered medical devices and diagnostic tools can contribute to more accurate and efficient healthcare delivery.
It's important to note that while these futuristic possibilities hold tremendous promise, their successful implementation will require extensive research, rigorous testing, regulatory approvals, and careful consideration of ethical, privacy, and security aspects.
Merger & Acquisition –
Merger and acquisition (M&A) activities in the medical device industry involve the consolidation, integration, or purchase of medical device companies by other companies. These transactions are typically aimed at achieving strategic objectives, such as expanding product portfolios, entering new markets, gaining competitive advantages, or leveraging synergies.
M&A activities in the medical device sector can take various forms, including:
- Horizontal M&A: This involves the merger or acquisition of companies operating in the same or similar areas of the medical device industry. It allows companies to expand their market share, eliminate competition, and achieve economies of scale. For example, a company specializing in orthopedic implants may acquire another orthopedic device manufacturer to broaden its product range and strengthen its market position.
- Vertical M&A: Vertical integration occurs when a company acquires or merges with a supplier, distributor, or service provider within the medical device supply chain. This strategy aims to streamline operations, control costs, enhance supply chain efficiency, and improve overall business performance. For instance, a medical device manufacturer may acquire a contract manufacturing organization (CMO) to bring manufacturing capabilities in-house and gain greater control over production processes.
- Diversification: Companies may engage in M&A activities to diversify their product offerings or enter new market segments. This strategy allows them to reduce reliance on a single product or market and mitigate risks. For example, a company specializing in cardiovascular devices may acquire a company with expertise in neurovascular devices to diversify its product portfolio and expand into a new therapeutic area.
- Technology Acquisition: M&A transactions may occur to acquire innovative technologies or intellectual property rights that complement or enhance existing product lines. This strategy enables companies to stay competitive and drive product innovation. For instance, a company focused on diagnostic imaging may acquire a startup with breakthrough imaging technology to strengthen its product capabilities.
- Geographic Expansion: M&A activities can facilitate entry into new geographic markets or enhance the global presence of a company. By acquiring companies with established distribution networks or market access in specific regions, companies can expand their reach and capture new customers. This strategy is particularly relevant for companies seeking international growth opportunities.
M&A transactions in the medical device industry are subject to regulatory scrutiny to ensure compliance with antitrust laws and to assess potential impacts on competition and patient welfare. Companies must also carefully consider factors such as financial valuation, integration challenges, cultural alignment, intellectual property rights, and regulatory compliance during the M&A process.
Overall, M&A activities in the medical device sector are driven by strategic objectives and aim to create synergies, drive growth, and enhance competitiveness in an evolving healthcare landscape.
Key segments in Medical Devices:
The medical device industry encompasses various segments that cater to different healthcare needs and specialties. Here are some key segments within the medical device industry:
- Diagnostic Devices: Diagnostic devices are used to detect and diagnose medical conditions. This segment includes devices such as imaging systems (X-ray, MRI, CT scanners), ultrasound machines, blood analyzers, molecular diagnostic instruments, and point-of-care testing devices. These devices provide healthcare professionals with critical information for accurate diagnosis and treatment planning.
- Therapeutic Devices: Therapeutic devices are designed to deliver treatments or therapies to patients. This segment includes devices such as implantable cardioverter-defibrillators (ICDs), pacemakers, insulin pumps, infusion pumps, nebulizers, ventilators, and dialysis machines. These devices aid in managing chronic conditions, delivering medications, providing respiratory support, and performing life-sustaining functions.
- Surgical Devices: Surgical devices are used during surgical procedures to assist surgeons in performing operations. This segment includes devices such as surgical instruments (forceps, scalpels, retractors), electrosurgical devices, surgical lasers, robotic surgical systems, and surgical staplers. These devices enhance precision, minimize invasiveness, and improve surgical outcomes.
- Monitoring Devices: Monitoring devices are used to track and measure physiological parameters of patients. This segment includes devices such as vital signs monitors, electrocardiographs (ECG/EKG), blood pressure monitors, glucose meters, pulse oximeters, sleep apnea monitors, and continuous glucose monitoring systems. These devices provide real-time data on a patient's vital signs, enabling healthcare professionals to monitor their condition and make informed decisions.
- Rehabilitation and Assistive Devices: Rehabilitation and assistive devices are designed to aid individuals with disabilities or impairments in their daily activities. This segment includes devices such as prosthetics, orthotics, mobility aids (wheelchairs, walkers), hearing aids, visual aids, and assistive technology for communication and mobility. These devices enhance mobility, sensory functions, and overall quality of life for individuals with disabilities.
- Implantable Devices: Implantable devices are surgically placed inside the body to restore or enhance specific bodily functions. This segment includes devices such as cardiac implants (pacemakers, defibrillators), neurostimulators, cochlear implants, artificial joints (hips, knees), and intraocular lenses. Implantable devices aim to improve patient health and function by replacing or augmenting damaged or impaired body parts.
- Home Healthcare Devices: Home healthcare devices are designed for use in non-hospital settings, allowing patients to receive care and monitoring in the comfort of their homes. This segment includes devices such as home infusion pumps, home dialysis machines, portable oxygen concentrators, sleep apnea machines, and remote monitoring devices. Home healthcare devices promote patient independence, reduce hospital stays, and enable personalized care.
These segments represent a broad overview of the medical device industry, and there are numerous subcategories and specialized devices within each segment. Advances in technology and innovation continue to drive the development of new and improved medical devices across these segments, aiming to enhance patient care and improve healthcare outcomes.
subsegments in Medical Devices:
The medical device industry consists of numerous subsegments that focus on specific areas of healthcare and address specialized needs. Here are some subsegments within the key segments of medical devices:
Diagnostic Devices:
- Imaging Devices: X-ray machines, magnetic resonance imaging (MRI) scanners, computed tomography (CT) scanners, ultrasound systems.
- In vitro Diagnostic (IVD) Devices: Blood analyzers, molecular diagnostic instruments, immunoassay systems, point-of-care testing devices.
- Diagnostic Imaging Contrast Agents: Contrast media used in imaging procedures to enhance visualization.
Therapeutic Devices:
- Cardiac Devices: Implantable cardioverter-defibrillators (ICDs), pacemakers, cardiac monitors, cardiac resynchronization therapy devices.
- Diabetes Management Devices: Insulin pumps, continuous glucose monitoring systems, blood glucose meters.
- Respiratory Devices: Nebulizers, ventilators, continuous positive airway pressure (CPAP) machines.
- Renal Devices: Dialysis machines, hemodialysis catheters, peritoneal dialysis systems.
Surgical Devices:
- Minimally Invasive Surgical Devices: Laparoscopic instruments, endoscopes, robotic surgical systems.
- Surgical Energy Devices: Electrosurgical devices, laser systems, ultrasonic dissectors.
- Surgical Instruments: Forceps, scissors, retractors, scalpels, clamps, suturing devices.
- Surgical Navigation Systems: Image-guided surgical systems, computer-assisted surgery devices.
Monitoring Devices:
- Vital Signs Monitors: Devices for measuring and monitoring parameters such as heart rate, blood pressure, temperature, and respiratory rate.
- Electrocardiographs (ECG/EKG): Devices for recording electrical activity of the heart.
- Pulse Oximeters: Devices for measuring oxygen saturation levels in the blood.
- Holter Monitors: Portable devices for continuous recording of ECG over a period of time.
Rehabilitation and Assistive Devices:
- Prosthetics: Artificial limbs and prosthetic devices.
- Orthotics: Devices such as braces, splints, and supports for musculoskeletal conditions.
- Mobility Aids: Wheelchairs, walkers, crutches, canes.
- Hearing Aids: Devices for individuals with hearing impairments.
- Visual Aids: Glasses, contact lenses, magnifiers, visual prostheses.
Implantable Devices:
- Cardiac Implants: Implantable pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices.
- Neurostimulators: Implantable devices for neuromodulation and electrical stimulation for conditions such as chronic pain, Parkinson's disease.
- Artificial Joints: Implantable hip, knee, shoulder, and other joint replacements.
- Cochlear Implants: Implantable devices for individuals with severe hearing loss.
- Intraocular Lenses: Artificial lenses used in cataract surgery to replace the natural lens.
Home Healthcare Devices:
- Home Infusion Pumps: Devices for administering medication or fluids at home.
- Home Dialysis Machines: Portable devices for performing dialysis at home.
- Portable Oxygen Concentrators: Devices for providing oxygen therapy on the go.
- Sleep Apnea Devices: Continuous positive airway pressure (CPAP) machines, oral appliances.
- Remote Monitoring Devices: Devices for remote patient monitoring and telehealth services.
These subsegments represent specific areas of focus within each key segment of medical devices, catering to specialized medical needs and conditions. They reflect the diverse range of medical devices available to address various healthcare challenges and improve patient outcomes.
Medical Devices Ecosystem:
- Manufacturers: Medical device manufacturers are responsible for designing, developing, and manufacturing medical devices. They conduct research, ensure regulatory compliance, and manage production processes to bring innovative and safe devices to the market.
- Regulatory Authorities: Regulatory authorities, such as the FDA in the United States and the European Medicines Agency (EMA) in Europe, play a crucial role in overseeing the safety, efficacy, and quality of medical devices. They establish guidelines, review applications, and issue approvals or clearances to ensure devices meet regulatory standards.
- Healthcare Providers: Healthcare providers, including hospitals, clinics, and healthcare professionals, utilize medical devices to diagnose, treat, and monitor patients. They rely on devices for accurate diagnostics, effective therapies, and improved patient care.
- Distributors: Distributors act as intermediaries between manufacturers and healthcare providers, facilitating the supply chain and ensuring devices reach end-users. They handle logistics, inventory management, sales, and after-sales support.
- Research and Development: Research and development (R&D) institutions, both within companies and academic settings, contribute to the advancement of medical devices. They conduct research, develop prototypes, and explore new technologies to drive innovation and improve medical device functionality.
- Testing and Certification Organizations: Testing and certification organizations play a vital role in evaluating the safety, performance, and compliance of medical devices. They conduct testing, inspections, and audits to ensure devices meet quality standards and regulatory requirements.
- Healthcare Professionals and Users: Healthcare professionals, including doctors, nurses, and technicians, play a critical role in the proper use and application of medical devices. They receive training, interpret device outputs, and provide care based on device-generated information. Patients and end-users also interact with medical devices for self-monitoring, home healthcare, and managing their health conditions.
- Support Services: Support services, such as maintenance and repair providers, calibration laboratories, and technical support teams, assist in device upkeep, troubleshooting, and ensuring devices are functioning optimally.
- Data Management and Analytics: With the rise of digital health, data management and analytics have become crucial in the medical devices ecosystem. Software platforms, cloud services, and analytics companies handle data collection, storage, analysis, and integration, enabling insights for personalized care, population health management, and clinical decision support.
- Patients and Caregivers: Patients and caregivers are essential stakeholders in the medical devices ecosystem. They rely on devices to monitor health conditions, manage treatments, and enhance quality of life. Their feedback, adherence to device usage, and experience provide valuable insights for device improvement and innovation.
The medical devices ecosystem encompasses a wide range of stakeholders, each playing a distinct role in the development, deployment, and utilization of medical devices to improve healthcare outcomes and patient well-being.
Top players:
The medical device industry is home to several top players that have established themselves as leaders in the global market. Here are some of the prominent companies in the medical device sector:
- Medtronic: Medtronic is a multinational medical device company based in Ireland. It offers a wide range of products across various therapeutic areas, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes management. Medtronic is known for its innovative devices such as pacemakers, defibrillators, insulin pumps, and surgical instruments.
- Johnson & Johnson: Johnson & Johnson is a diversified healthcare company with a significant presence in the medical device industry. Its subsidiary, Ethicon, is a leader in surgical devices, including sutures, staplers, and energy devices. Johnson & Johnson's medical device portfolio also includes orthopedic implants, cardiovascular devices, diabetes care products, and vision care solutions.
- Abbott Laboratories: Abbott is a global healthcare company that develops and manufactures a wide range of medical devices and diagnostics. Its product offerings include cardiovascular devices (e.g., stents, heart valves), diabetes care products (e.g., glucose monitoring systems, insulin pumps), diagnostic instruments, molecular diagnostics, and point-of-care testing devices.
- Siemens Healthineers: Siemens Healthineers is a leading medical technology company focused on diagnostic imaging systems, laboratory diagnostics, and advanced healthcare IT solutions. The company's products range from X-ray, CT, and MRI systems to in vitro diagnostics equipment and clinical laboratory analyzers.
- GE Healthcare: GE Healthcare, a division of General Electric, provides a comprehensive portfolio of medical devices, including diagnostic imaging systems, ultrasound machines, patient monitoring systems, and life support equipment. The company also offers healthcare IT solutions and services.
- Stryker Corporation: Stryker is a global medical technology company specializing in orthopedics, medical and surgical equipment, and neurotechnology and spine products. It offers a wide range of innovative devices for joint replacement, trauma surgery, surgical navigation, and neurovascular interventions.
- Becton, Dickinson and Company (BD): BD is a leading global medical technology company that develops and manufactures a diverse range of medical devices and solutions. The company's product offerings include injection and infusion systems, diagnostic systems, surgical instruments, and advanced bioprocessing technologies.
- Boston Scientific Corporation: Boston Scientific is a renowned medical device company focused on areas such as cardiovascular interventions, rhythm management, urology and pelvic health, endoscopy, and neuromodulation. It develops and markets devices for procedures like coronary stenting, pacemakers, catheters, and endoscopic tools.
- Zimmer Biomet Holdings: Zimmer Biomet is a global leader in musculoskeletal healthcare, specializing in orthopedic implants, surgical instruments, and advanced technologies for joint reconstruction, sports medicine, spine surgery, and dental applications.
- Philips Healthcare: Philips Healthcare offers a wide range of medical devices and solutions, including imaging systems (such as CT and MRI), patient monitoring systems, respiratory care devices, and home healthcare solutions. The company focuses on integrating technology and data to improve patient outcomes and healthcare efficiency.
These companies have established strong market positions through their product portfolios, technological innovation, global presence, and commitment to advancing healthcare. However, it's important to note that the medical device industry is highly competitive, and there are several other notable players contributing to the advancement of medical technology.
High grown opportunities:
The medical device industry offers numerous high-growth opportunities driven by various factors such as technological advancements, increasing healthcare needs, and evolving market dynamics. Here are some key areas that present significant growth opportunities in the medical device sector:
- Digital Health and Connected Devices: The integration of digital technologies and connectivity in medical devices is transforming healthcare delivery. Opportunities exist in the development of wearable devices, remote patient monitoring systems, mobile health applications, telemedicine platforms, and digital therapeutics. These technologies enhance patient engagement, enable real-time monitoring, and facilitate personalized healthcare delivery.
- Minimally Invasive and Robotic-Assisted Surgery: Minimally invasive surgical techniques and robotic-assisted surgery have gained significant popularity due to their potential to reduce invasiveness, shorten recovery times, and improve surgical outcomes. The demand for advanced surgical instruments, robotic systems, and imaging technologies for minimally invasive procedures is expected to grow as more healthcare providers adopt these techniques.
- Personalized Medicine and Point-of-Care Diagnostics: Advances in genomics, molecular diagnostics, and personalized medicine have created opportunities for the development of innovative diagnostic devices. Point-of-care testing devices, genetic testing platforms, and companion diagnostics are witnessing growth as they enable targeted treatments, improve disease management, and enhance patient outcomes.
- Artificial Intelligence and Machine Learning: Artificial intelligence (AI) and machine learning (ML) technologies have the potential to revolutionize medical devices by improving diagnostic accuracy, predicting patient outcomes, and enabling real-time data analysis. AI-powered imaging systems, predictive analytics tools, and decision support systems are emerging as growth areas within the medical device industry.
- Remote Monitoring and Home Healthcare: The shift towards patient-centered care and the aging population have fueled the demand for remote monitoring devices and home healthcare solutions. Remote patient monitoring systems, wearable health trackers, and home-based medical devices are expected to experience significant growth as they enable continuous monitoring, early intervention, and personalized care outside traditional healthcare settings.
- Advanced Implantable Devices: The market for implantable medical devices, such as cardiac implants, neurostimulators, and orthopedic implants, continues to grow as the aging population increases and the demand for improved quality of life rises. Advancements in materials, biocompatibility, and design are driving the development of next-generation implantable devices with enhanced functionality and durability.
- Emerging Markets: Emerging markets, particularly in Asia, Latin America, and Africa, offer substantial growth opportunities for medical device companies. Rising healthcare expenditures, increasing access to healthcare services, and expanding middle-class populations are driving demand for medical devices in these regions. Companies that can effectively navigate regulatory landscapes, adapt to local needs, and provide affordable solutions have the potential for significant growth in emerging markets.
It's important to note that the medical device industry is subject to regulatory requirements and challenges related to reimbursement, intellectual property, and market competition. Companies that can navigate these complexities while addressing evolving healthcare needs stand to benefit from the high-growth opportunities within the medical device sector.
Challenges in Medical Devices Industry:
The medical device industry faces several challenges that impact its growth, innovation, and market dynamics. Here are some key challenges in the medical device industry:
- Regulatory Compliance: Medical devices are subject to strict regulations and standards to ensure safety, efficacy, and quality. Obtaining regulatory approvals, navigating complex compliance requirements, and managing post-market surveillance can be time-consuming and costly for medical device companies.
- Reimbursement and Pricing Pressures: Reimbursement policies and pricing pressures pose challenges for medical device manufacturers. Negotiating reimbursement contracts with healthcare payers and demonstrating cost-effectiveness and clinical value are essential to gain market access and sustain profitability.
- Technological Advancements and Innovation: The medical device industry is highly competitive, and staying at the forefront of technological advancements is critical. Companies face the challenge of continuously innovating and developing new devices with enhanced features, improved outcomes, and cost-effectiveness.
- Intellectual Property Protection: Protecting intellectual property (IP) rights is crucial for medical device companies. The industry is susceptible to patent disputes, infringement issues, and challenges in safeguarding proprietary technologies. Ensuring strong IP protection and defending against potential legal threats are ongoing challenges.
- Market Access and Global Expansion: Expanding into new markets, especially international markets, can be challenging due to variations in regulatory requirements, cultural differences, and market dynamics. Establishing distribution networks, complying with local regulations, and understanding market needs are critical for successful market access and expansion.
- Cost and Time to Market: Developing and commercializing medical devices involve significant investments in research and development, clinical trials, and manufacturing. Long development timelines, cost overruns, and delays in obtaining regulatory approvals can impact companies' ability to bring products to market in a timely and cost-effective manner.
- Healthcare System Adoption: Healthcare systems and providers may be slow to adopt new technologies and devices due to factors such as budget constraints, resistance to change, and concerns about reimbursement. Demonstrating clinical evidence, cost-effectiveness, and addressing barriers to adoption are essential for widespread acceptance and adoption of medical devices.
- Data Security and Privacy: With the increasing use of connected devices and digital health technologies, data security and privacy have become critical concerns. Protecting patient data, ensuring cybersecurity measures, and complying with data privacy regulations present ongoing challenges for medical device companies.
- Supply Chain Disruptions: Disruptions in the global supply chain, such as raw material shortages, transportation issues, and geopolitical events, can impact the production and availability of medical devices. Ensuring supply chain resilience and mitigating risks are vital to maintain uninterrupted device availability.
- Healthcare Cost Containment: Healthcare systems globally are under pressure to contain costs. Medical device companies need to address the cost-effectiveness of their devices, demonstrate economic value, and work collaboratively with healthcare providers to meet cost containment objectives.
Navigating these challenges requires strategic planning, collaboration with stakeholders, investment in research and development, and a deep understanding of market dynamics. Companies that can effectively address these challenges have a better chance of succeeding in the competitive medical device industry.
High CAGR geography:
The Compound Annual Growth Rate (CAGR) of the medical device industry can vary across different geographies due to factors such as population demographics, healthcare infrastructure, regulatory environments, and economic growth. While it is difficult to predict the precise CAGR for specific geographies, there are regions that have shown potential for high growth in the medical device sector. Here are a few geographies that have been identified as having a high CAGR for medical devices:
- Asia-Pacific: The Asia-Pacific region has witnessed significant growth in the medical device market. Countries like China, India, and Japan have large populations with increasing healthcare needs. Rising disposable incomes, improving healthcare infrastructure, and government initiatives to enhance healthcare access have contributed to the growth of the medical device sector in this region.
- Latin America: Latin America is another geography with a high growth potential for medical devices. Countries such as Brazil, Mexico, and Argentina have expanding middle-class populations and increasing healthcare expenditures. The demand for medical devices in areas such as diagnostic imaging, surgical instruments, and cardiovascular devices is expected to grow in this region.
- Middle East and Africa: The Middle East and Africa region is experiencing rapid growth in healthcare infrastructure and spending. Countries like Saudi Arabia, United Arab Emirates, South Africa, and Kenya are investing in modernizing healthcare facilities and expanding access to medical services. This creates opportunities for medical device companies, particularly in areas such as diagnostic imaging, patient monitoring, and surgical equipment.
- North America: Despite being a mature market, North America, especially the United States, continues to offer growth opportunities in the medical device sector. Technological advancements, increasing chronic disease prevalence, and a focus on value-based healthcare are driving the demand for innovative medical devices and technologies in this region.
- Europe: Europe remains a significant market for medical devices, with countries like Germany, France, and the United Kingdom being major contributors. The region's aging population, favorable reimbursement policies, and a focus on healthcare modernization create opportunities for medical device companies, particularly in areas such as implantable devices, diagnostic imaging, and in vitro diagnostics.
see less
-
Healthcare regulations refer to sharp instruments as medical objects or instruments necessary for the exercise of specific health care activities such as making cuts or pricks. The users of these objects/instruments (the healthcare providers) bear a significant risk of injury and/or are susceptible to infections if the sharp is contaminated with infectious blood. Sharps injuries are primarily associated with occupational transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV), but they have been implicated in the transmission of more than 20 other pathogens. Sharps safety devices have engineering controls that are built into the product and prevent sharps injuries.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global immunochemistry instruments and reagents market is expected to reach $24.5 billion by 2019 from $17.3 billion in 2014, growing at a CAGR of 7.2% from 2014 to 2019. There is a rising focus on biomarker development across the globe as they help in detection of various diseases in their initial stage. Immunochemistry plays a crucial role in the development of biomarkers thus with the growing demand of biomarkers, the market for immunochemistry instruments and reagents will also flourish. Furthermore, government support in terms of funds and grants has also provided much needed impetus to this market. Moreover, increasing focus on drug monitoring and growing incidences of various diseases are other factors driving the growth of the market. In addition to this, technological advancements due to which automated and more accurate instruments are present in the market is another major factor propelling the growth of the market. However, factors such as stringent regulations for the development and launch of immunochemistry products and low adoption rate of automated immunochemistry products in developing economies due to high cost can hinder the growth of the market in coming years.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cannabis, also known as marijuana, is a plant that is known for its psychoactive, medicinal, and fibrous properties. Medical cannabis has been proven effective in treating various medical conditions such as chronic pain, arthritis, seizure disorders, Crohn’s disease, and Parkinson’s disease; it is also found to be effective in reducing nausea caused due to chemotherapy, stimulating appetite in AIDs patients, controlling muscular spasms caused by multiple sclerosis, and reducing intraocular pressure in patients suffering from glaucoma.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The US pharmaceutical drug delivery market is projected to reach USD 1.24 billion by 2031 from USD 0.94 billion in 2026, at a CAGR of 5.8% during the forecast period. Some of the prominent players in the US pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Pfizer Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson and Company (US), Merck & Co., Inc. (US), Amgen, Inc. (US), AbbVie Inc. (US), Gilead Sciences, Inc. (US), Eli Lilly and Company (US), Bristol-Myers Squibb (US), Biogen (US), Baxter International (US), West Pharmaceutical Services (US), Catalent Pharma Solutions (US), and Novartis (Switzerland).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Latin America in vitro diagnostics (IVD) market is expected to grow from an estimated USD 5.87 billion in 2026 to reach USD 8.13 billion by 2031, at a CAGR of 6.7% during the forecast period. The Key Players are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Siemens Healthineers AG (Germany), bioMérieux (France), Thermo Fisher Scientific Inc. (US), QuidelOrtho Corporation (US), Illumina, Inc. (US), Becton, Dickinson and Company (US), and Agilent Technologies, Inc. (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The US enteral feeding devices market is projected to reach USD 1.70 billion by 2032 from USD 1.19 billion in 2026, growing at a CAGR of 6.1% during the forecast period. The Key Players Cardinal Health (US), Avanos Medical (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Baxter International (US), Boston Scientific Corporation (US), Cook Medical (US), Conmed Corporation (US), Moog Inc. (US), Hollister Incorporated (US), Amsino International (US), Teleflex Incorporated (US), B. Braun SE (Germany), Fresenius Kabi (Germany), and Danone S.A. (France).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Global Gastroscopes market is expected to reach USD 2.57 billion by 2023 from USD 1.51 billion in 2018, growing at a CAGR of 11.2 % from 2018 to 2023. Growing occurrences of gastric disorders like ulcers and improvements in the gastroscope technology and equipments are expected to drive the growth of the market during the forecast period. The high cost of the product and the subsequent risk of infections upon its use may restrain the growth of the market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global breast pump market is expected to reach $1.01 Billion by 2022 from $0.71 Billion in 2017, growing at a CAGR of 7.3% from 2017 to 2022. Increasing technological advancements in medical devices; rising number of new born across the globe; increasing women employment; increasing healthcare expenditure are the major driving factors for breast pump market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global wound assessment Market was estimated at USD 13.00 million in 2018, and is estimated to reach USD 16 million by 2023, growing at a CAGR of 4.2% from 2018 to 2023. Recent studies revealed that wound treatment cost may reduce by ~89% and recently launched wound intelligent devices. Also, enhance the wound healing process by nine times. Penetration of advanced wound management products will be significantly impacting emerging economies as intelligent digital devices helps to curb the wound treatment cost.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The STDs diagnostics market size is projected to reach $99,431.6 million by 2027 from $91,441.5 million in 2022, at a CAGR of 5.6% during the forecast period. Sexually transmitted diseases diagnostics market is driven by factors such as global prevalence of HIV, CT/NG, and other STDs and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements. On the other hand, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the coming years.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The US digital diabetes management market is projected to reach USD 22.67 billion by 2031 from USD 12.94 billion in 2026, at a CAGR of 11.9%. The Key Players include Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Health2Sync (Taiwan), Tandem Diabetes Care (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Ascensia Diabetes Care Holdings AG (Switzerland), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), Pendiq GmbH (Germany), One Drop (US), Decide Clinical Software GmbH (Austria), and BeatO (India)
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Middle East & Africa in vitro diagnostics market is valued at an estimated USD 3.49 billion in 2026 and is projected to reach USD 4.42 billion by 2031, at a CAGR of 4.8% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Danaher (US), Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), and QuidelOrtho Corporation (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Asia Pacific (APAC) pharmaceutical drug delivery market is projected to reach USD 687.9 million by 2031 from USD 479.7 million in 2026 at a CAGR of 7.5% during the forecast period. Some of the major players in the APAC pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Pfizer Inc. (US), Terumo Corporation (Japan), Becton, Dickinson and Company (US), Merck & Co., Inc. (US), B. Braun (Germany), Gerresheimer AG (Germany), Cipla (India), Eli Lilly and Company (US), Novartis (Switzerland), Biogen (US), Baxter International (US), West Pharmaceutical Services (US), Sun Pharmaceutical Industries (India), GlaxoSmithKline (UK).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global polyvinylpyrrolidone market is projected to grow at a highest CAGR during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global chemiluminescent technology market is expected to reach USD 14,286.8 million by 2023 from USD 10,983.3 million in 2018, growing at a CAGR of 5.4% from 2018 to 2023. Growing prevalence of infectious and chronic diseases; extensive use of immunoassay in oncology; technological advancements; cost-effectiveness & rapid analysis; and growth in the biotechnology and pharmaceutical sector are some of the growing factors for this market. Apart from this, increasing R&D investments in biotechnological industries; increasing government funding on cancer research and vaccine development are the major driving factors that fuel the chemiluminescent technology market over the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
LATAM Angiography Equipment Market
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Anastomosis is a connection made surgically between adjacent blood vessels, parts of the intestine, or other channels of the body. It is achieved by surgically suturing or stapling the two ends of the channel to restore or form a new connection. Vascular anastomosis is performed to connect the blood vessels, for e.g. in cardio vascular surgeries such as by-pass surgery. Similarly, gastrointestinal anastomosis is performed for bowel re-sectioning, for e.g. in Gastrojejunostomy. With increasing ailments of cardiovascular diseases, gastrointestinal surgeries, and organ transplants has resulted in demand for anastomosis devices.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global antiseptics and disinfectants market size is projected to reach USD 48.2 million by 2027 from USD 35.1 million in 2022, at a CAGR of 10.0% during the forecast period. Market is driven by factors such as global prevalence of infectious diseases, increased incidence of HAIs and the growing awareness for sanitization and infection control. On the other hand, an rising number of adverse effects due to chemical antiseptics and disinfectants is expected to limit market growth to a certain extent in the coming years.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global water electrolysis machine market is projected to grow at a highest CAGR during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The US telehealth & telemedicine market is projected to reach USD 83.63 billion by 2030 from USD 51.40 billion in 2025, at a high CAGR of 10.2% during the forecast period. The Key Players Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Teladoc Health, Inc. (US), Cisco Systems, Inc. (US), Zoom Communications, Inc. (US), Doximity, Inc. (US), GE Healthcare (US), American Well (US), Siemens Healthineers AG (Germany), Epic Systems Corporation, Included Health, Inc. (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), Caregility (US), CVS Health (US), Evernorth Health, Inc. (US), Elation (US), Iron Bow Technologies (US), Oracle (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The extracellular matrix is the structural substance that surrounds cells in nearly all tissues in the body. The composition of the extracellular matrix varies by the type of tissue, it is generally composed of four major types of molecules, namely, Structural proteins, glycoproteins, glycosaminoglycan’s, and proteoglycans. Structural proteins, such as collagen and elastin, provide the main structural framework in extracellular matrix. Glycoproteins help bind cells to the collagen. Glycosaminoglycans and proteoglycans keep the matrix well hydrated by absorbing water and binding growth factors.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global hospital housekeeping supplies market is expected to reach USD 5.6 Billion by 2022 from USD 4.9 Billion in 2016, growing at a CAGR of 2.3% from 2016 to 2022. Increasing incidences of various diseases; rising awareness about sanitation and various infection associated diseases; increasing number of hospital-acquired infections (HAIs) cases; and rising number of hospitals in developing countries are some of the major driving factors driving the growth of the global hospital housekeeping supplies market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global portable oxygen concentrator (POC) market is expected to reach USD 346.8 million in 2023 from USD 204.9 million in 2018, growing at a CAGR of 11.1%. Increasing prevalence of COPD, Asthma, respiratory distress syndrome, and other respiratory disease are the major driving factors for this market. In addition to this, increasing geriatric population also support the growth of this market to a certain extent. Moreover, shift from traditional cylinders to portable oxygen concentrator fuel the demand for portable oxygen concentrators during forecast period. On the other hand, increasing focus of players on emerging market also expected to increase the demand for POC during forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Mouth ulcers, also called as canker sores, are painful sores that are formed on the soft tissue in the mouth including lips, cheek, tongue, floor and roof of the mouth, and gums. Mouth ulcers can make it difficult for some patients to eat, drink, and brush teeth. Most mouth ulcers are benign and recurring and get cleared up within 1-2 weeks on their own. Some common causes of mouth ulcer are acidic foods, biting the tongue or inside of the cheek, braces, poor-fitting dentures, and other apparatus that may rub against the mouth and gums, deficiency of vitamins, stress, anxiety, infections, and may be a sign of other diseases such as Crohn's disease, celiac disease, or HIV.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global incubator systems market was valued USD 281.3 million in 2016 and is expected to reach USD registering a CAGR of 6.2% from 2017 to 2023. Incubator is the biomedical device that primarily provides humidity, warmth, and oxygen to the body in a controlled environment. The infant incubator comprises of an enclosed chamber with a small mattress on the top covered by a rigid plastic cover. This chamber protects from dust, noise, and infection. Infant incubator is widely used worldwide owing to high incidence of preterm birth rates. For instance, each year globally, around 15 million preterm babies are born. Owing to this, there is a high need of infant incubators worldwide.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global ureteral stents market is expected to reach USD 376.0 million by 2023 from USD 278.3million in 2018, growing at a CAGR of 6.2%. Increasing incidence of kidney diseases; rising adoption of minimally invasive surgeries; technological advancements in bio absorbable ureteral stents and rising number of kidney transplants are some of the major factors driving the growth of the global ureteral stents market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global PTA balloon catheter market size is estimated to be valued at ~USD 1.8 Billion in 2021 and is expected to grow at a CAGR of 7.1% during the forecast period (2022-2027). The market is driven by factors such as rapid growth in the geriatric population and the subsequent increase in the prevalence f peripheral vascular diseases and coronary artery diseases, favorable reimbursement scenarios for peripheral vascular and coronary artery procedures, increased number of product approvals, increase the prevalence of diabetes, the rising rate of tobacco consumption, and growth in the incidences of obesity. On the other hand, a rise in the availability of alternative treatments, and a dearth of skilled professionals wth expertise in peripheral vascular devices, are expected to limit market growth to a certain extent in the coming years.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The medical textile testing deals with the performance evaluation of the apparel, clothing, and fabrics used in hospitals. The global medical textile testing market is estimated to grow at a high CAGR during the forecast period. Rising demand for medical textile products coupled with rising importance of safety and hygiene in medical textile industry have spurred the medical textile testing market across the globe. Technological developments, stringent quality and safety regulations in the medical textile industry, and rising healthcare expenditure are some of the other key factors that are further driving the growth of market. However, lack of awareness/ignorance about importance of safety and hygiene of medical textiles in developing and under developed countries and high cost involved in the performance testing of medical products pose as barriers to the market growth.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Non-mechanical equipment or soft products are used with or without mechanical equipment to transfer or relocate a patient. Non-mechanical devices comprise slide sheets, transfer belts, roller sheets and single-use patient transfer mats. Slide sheets, designed to reduce friction between surfaces, aid in transferring patients from one bed to another. Transfer belts worn by patients provide caregivers with a safe and secure grip. These devices are not only safe and comfortable for patients but also beneficial for caregivers as they reduce the risk of injuries during patient transfers/relocation.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global personalized medicine market is projected to reach USD ~500 billion by 2027 from USD 300 Billion in 2022, at a CAGR of 11% during the forecast period
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global vapor chamber market is projected to grow at a highest CAGR during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global microwave power supply market is projected to grow at a highest CAGR during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The worldwide use of both magnetic resonance imaging (MRI) and pacing devices has vastly increased in recent years and an important number of implanted patients likely will need an MRI over the course of the lifetime of their device.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Cyclotrons are one of the most prevalent forms of accelerators used to make radioisotopes (radioactive atoms) that can be used for medical imaging and research. A prominent area of application of cyclotrons involves the production of short-lived neutron deficient radiotracers for use in emission tomography, especially positron emission tomography (PET). Medical cyclotrons are used around the world to produce medical isotopes such as Fluorine-18 and Carbon-11. Significant advantage of cyclotron is that cyclotrons generate comparatively lesser radioactive waste compared to huge nuclear reactors.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global bariatric surgery market is expected to reach USD 2.83 Billion by 2022 from USD 1.82 Billion in 2017, growing at a CAGR of 9.2% from 2018 to 2022. Prominent players in the bariatric surgery market are Ethicon US, LLC.(Johnson and Johnson) (US), Medtronic Plc (Ireland), B.Braun Melsungen AG (Germany), Olympus (Japan), Allergan Inc. (US), Intuitive Surgical, Inc. (US), Cook Medical (US), CONMED Corporation (US), Apollo Endosurgery, Inc. (US) , and Cousin Biotech (France).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The US injectable drug delivery market is expected to grow from USD 285.81 billion in 2025 to USD 465.15 billion by 2031, at a compound annual growth rate (CAGR) of 8.5% during the forecast period. The Key Players BD (US), West Pharmaceutical Services, Inc. (US), Cardinal Health (US), Baxter (US), B. Braun SE (Germany), Pfizer Inc. (US), Johnson & Johnson (US), Merck & Co., Inc. (US), Eli Lilly and Company (US), and AbbVie Inc. (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global cardiac ablation market is poised to grow at a CAGR of 12.5% during 2014-2019, and is expected to reach a value of ~$883.1 Million in 2019. A number of factors such as growing geriatric population coupled with increasing population base of cardiovascular disease patients, technological advancements in the field of ablation devices, and growing awareness about benefits of cardiac ablation procedures over conventional therapeutic and surgical procedures are fuelling the growth of the global cardiac ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global medical carts market is expected to reach USD 3.56 billion by 2023 from USD 1.82 billion in 2018, growing at a CAGR of 14.3%. Increasing adoption of the electronic medical records and increasing incidences of musculoskeletal injury and technological advancement are some of the major factors driving the growth of the global medical carts market. However, increasing price competition among manufacturers are hindering the growth of this market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global healthcare API market size is projected to reach USD 310.0 million by 2030 from USD 215.5 million in 2022, at a CAGR of 3.5% during the forecast period. The Healthcare API market is mainly driven by factors such as adoption of Application Programming Interfaces (API) integrated Electronic Health Records (EHRs) that provide simplicity and ease of healthcare data accessibility, improved patient outcomes increased patient satisfaction, and development in the care quality are propelling the market expansion.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Ultrasound technology plays a crucial role in medical imaging and diagnostics, offering non-invasive, real-time imaging of internal structures in the body.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The Europe dental equipment market is projected to reach USD 4.15 billion by 2031 from USD 2.88 billion in 2025, at a CAGR of 5.3% during the forecast period. The Key Players include DENTSPLY SIRONA (US), Planmeca OY (Finland), Envista (US), Align Technology, Inc. (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Ivoclar Vivadent (Germany), GC Corporation (Japan), Midmark Corporation (US), Institut Straumann AG(Switzerland), Solventum (US), and Ultradent Products, Inc. (US).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global Hydrogen Peroxide De-Contamination market size is projected to reach USD xx million by 2027 from USD xx million in 2022, at a CAGR of xx% during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
The global nuclear magnetic resonance spectroscopy market is projected to reach USD 1.4 billion by 2027 from USD 1.1 Billion in 2022, at a CAGR of 5% during the forecast period. The growth in the nuclear magnetic resonance spectroscopy market is majorly driven by the expansion of the research pipeline of pharma and biotech companies, the increased number of drug development initiatives, and the higher adoption of integrated NMR platforms (such as NMR-LC and NMR-MS).
- Published: February 2026
- Price: $ 4950
- TOC Available: